| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alafenamide |
| Brand | Genvoya® |
| Indication | For the treatment of adults and adolescents infected with human immunodeficiency virus – 1 (HIV-1). |
| Assessment Process | |
| Rapid review commissioned | 24/11/2015 |
| Rapid review completed | 05/01/2016 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |